Quantum Biopharma (QNTM) Change in Inventory (2019 - 2026)
Quantum Biopharma recorded quarterly Change in Inventory of $665.0 in Q1 2026, down 97.39% quarter-over-quarter from $25489.0 in Q4 2025, and down 97.16% year-over-year from $23386.0 in Q1 2025.
Quantum Biopharma's Change in Inventory history runs 4 years deep, the most recent figure standing at $665.0 for Q1 2026.
- In Q1 2026, Change in Inventory fell 97.16% year-over-year to $665.0; the TTM figure through Mar 2026 stood at -$67702.0 (up 27.87% YoY), while the FY2025 annual figure was $52133.0, down 55.53% from the prior year.
- Change in Inventory came in at $665.0 for Q1 2026 at Quantum Biopharma, down from $25489.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $77622.0 in Q3 2025 to a low of -$117242.0 in Q4 2024.
- A 3-year average of $14464.8 and a median of $24437.5 in 2025 frame the typical range for Change in Inventory.
- Across the five-year window, Change in Inventory soared 121.74% in 2025 and sank 97.16% in 2026, its largest moves.
- Quantum Biopharma's Change in Inventory stood at -$117242.0 in 2024, then surged by 121.74% to $25489.0 in 2025, then slumped by 97.39% to $665.0 in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered $665.0, $25489.0, and $77622.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 665.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 97.70 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -26.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.32 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51,468.00 |
| Mar 31, 2026 | 51,468.00 |
| Dec 31, 2025 | 25,489.00 |
| Dec 31, 2025 | 25,489.00 |
| Sep 30, 2025 | 77,622.00 |
| Sep 30, 2025 | 77,622.00 |
| Jun 30, 2025 | 76,869.00 |
| Jun 30, 2025 | 76,869.00 |
| Mar 31, 2025 | 23,386.00 |
| Mar 31, 2025 | 23,386.00 |
| Dec 31, 2024 | -117,242.00 |
| Dec 31, 2024 | -117,242.00 |
| Dec 31, 2019 | 714,274.74 |
| Dec 31, 2019 | 714,274.74 |